Smoking-attributable mortality in Portugal and its regions in 2019

Introduction and objectives: Timely regional-specific estimates of smoking-attributable mortality (SAM) are crucial for healthcare planning and tobacco control advocacy. Currently, this information is lacking in Portugal. The aim of this study was to estimate SAM by region in 2019 among the Portugue...

Descripción completa

Detalles Bibliográficos
Autores: Rey Brandariz, Julia, Ravara, Sofía, López Vizcaíno, Esther, Santiago Pérez, María Isolina, Ruano Raviña, Alberto, Candal Pedreira, Cristina, Varela Lema, María Leonor, Mourino, Nerea, Aguiar, Pedro, Pérez Ríos, Mónica
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universidad de Santiago de Compostela (USC)
Repositorio:Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Idioma:inglés
OAI Identifier:oai:minerva.usc.gal:10347/44561
Acceso en línea:https://hdl.handle.net/10347/44561
Access Level:acceso abierto
Palabra clave:tobacco
mortality
cancer
cardiovascular disease
respiratory disease
Portugal
3202 Epidemologia
3212 Salud pública
Descripción
Sumario:Introduction and objectives: Timely regional-specific estimates of smoking-attributable mortality (SAM) are crucial for healthcare planning and tobacco control advocacy. Currently, this information is lacking in Portugal. The aim of this study was to estimate SAM by region in 2019 among the Portuguese population aged ≥35 years. Methods: SAM was estimated using an independent-prevalence method. Observed mortality was obtained from Portugal Statistics; lung cancer mortality rates in smokers and never-smokers from the Cancer Prevention Study I–II and updated relative risks from five contemporary US cohort studies. SAM was estimated for each NUTS-II region by sex, age, and cause of death. Crude SAM rates, sex- and age-specific rates, and age-adjusted rates were calculated using the direct method. Results: In 2019, tobacco consumption caused 13,847 deaths, representing 12.3% of total mortality among the Portuguese population aged ≥35 years. Of the total SAM, 71.2% occurred in men and 22.2% in those under 65 years; 42.5% was due to cancer, 35.4% to cardiovascular and metabolic diseases, and 22.2% to respiratory diseases. SAM greatly varied among regions from 2.1% in Madeira to 36.2% in the North region. In men, cancer was the leading cause of death in all regions, while in women it was cardiovascular and metabolic diseases. Conclusion: In Portugal, tobacco-mortality burden is high and varies significantly by region, sex, and age. Therefore, estimates disaggregated by sociodemographic data and region may better support decision-makers while tailoring and implementing tobacco control policies addressing health population needs. The apparent lower tobacco burden among women and in some Portuguese regions may dramatically rise in the near future. This and the high SAM in Portugal, particularly in some regions, highlights the need to accelerate tobacco control both at national and regional levels.